Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1609868231
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
San Juan City Hospital, Medical Center
San Juan, PR, 00936
Phone (787) 766-2222
Medicare paid, 2024
$6,151
83 services
Medicare patients, 2024
37
Average age 75
Drug cost, 2024
$9.0M
36,573 prescriptions
Company payments, 2025
$74.74
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos R Figueroa Nunez was code 99214 (office e&m - established), 83 times for 37 patients. In total Carlos R Figueroa Nunez billed 83 services in 1 codes, and Medicare paid $6,151.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 83 | 37 | $74.10 | $6,151 |
By year: 2022 $6,171 for 95 services; 2023 $6,103 for 99 services; 2024 $6,151 for 83 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos R Figueroa Nunez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 5,408 prescriptions and refills. In total Carlos R Figueroa Nunez wrote 36,573 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 5,408 | 8,082 | 1,045 | $363K |
| Rosuvastatin Calcium Generic | 3,140 | 4,585 | 730 | $29K |
| Trulicity Dulaglutide | 3,098 | 3,186 | 394 | $3.2M |
| Farxiga Dapagliflozin Propanediol | 2,106 | 2,405 | 401 | $1.4M |
| Lantus Insulin Glargine,hum.Rec.Anlog | 2,074 | 2,438 | 336 | $217K |
| Metformin Hcl Generic | 1,899 | 2,721 | 423 | $9,598 |
| Atorvastatin Calcium Generic | 1,487 | 2,351 | 414 | $12K |
| Jardiance Empagliflozin | 1,291 | 1,467 | 250 | $903K |
| Simvastatin Generic | 1,286 | 2,025 | 331 | $6,524 |
| Alendronate Sodium Generic | 1,085 | 1,575 | 250 | $8,127 |
| Ozempic Semaglutide | 916 | 954 | 107 | $927K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 816 | 1,843 | 225 | $103K |
| Pen Needle Pen Needle, Diabetic | 493 | 557 | 113 | $6,847 |
| Pioglitazone Hcl Generic | 393 | 465 | 78 | $4,083 |
| Fenofibrate Generic | 391 | 514 | 117 | $7,360 |
Brand drugs: 18,812 claims; generic drugs: 14,178 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos R Figueroa Nunez $74.74 ($74.74 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $29.77.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.